Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khuri

Showing results (931-940 of 969) with videos related to

Pageof 97
Sort By:
The Journal of Biological Chemistry|May 5, 2017
HMG-CoA synthase 1 is a synthetic lethal partner of BRAF<sup>V600E</sup> in human cancersLiang Zhao, Jun Fan, Siyuan Xia, et al.
Cancer|July 19, 2002
The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapyRoy S Herbst, Fadlo R Khuri, Charles Lu, et al.
Science Translational Medicine|August 30, 2019
Simultaneous transrectal ultrasound and photoacoustic human prostate imagingSri-Rajasekhar Kothapalli, Geoffrey A Sonn, Jung Woo Choe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Phase I study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in solid tumorsFadlo R Khuri, Bonnie S Glisson, Edward S Kim, et al.
Elife|September 6, 2017
<i>C. elegans</i> avoids toxin-producing <i>Streptomyces</i> using a seven transmembrane domain chemosensory receptorAlan Tran, Angelina Tang, Colleen T O'Loughlin, et al.
Journal of the National Cancer Institute|April 20, 2001
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancerS M Lippman, J J Lee, D D Karp, et al.
Nature Communications|February 17, 2017
The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategiesZenggang Li, Andrei A Ivanov, Rina Su, et al.
JCI Insight|March 15, 2017
Targeting adhesion signaling in <i>KRAS, LKB1</i> mutant lung adenocarcinomaMelissa Gilbert-Ross, Jessica Konen, Junghui Koo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2020
A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid TumorsTaofeek K Owonikoko, R Donald Harvey, Bradley Carthon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2013
Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studiesDong M Shin, Hongzheng Zhang, Nabil F Saba, et al.
Pageof 97

Showing results (931-940 of 969) with videos related to

Sort By:
Pageof 97
The Journal of Biological Chemistry|May 5, 2017
HMG-CoA synthase 1 is a synthetic lethal partner of BRAF<sup>V600E</sup> in human cancersLiang Zhao, Jun Fan, Siyuan Xia, et al.
Cancer|July 19, 2002
The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapyRoy S Herbst, Fadlo R Khuri, Charles Lu, et al.
Science Translational Medicine|August 30, 2019
Simultaneous transrectal ultrasound and photoacoustic human prostate imagingSri-Rajasekhar Kothapalli, Geoffrey A Sonn, Jung Woo Choe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Phase I study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in solid tumorsFadlo R Khuri, Bonnie S Glisson, Edward S Kim, et al.
Elife|September 6, 2017
<i>C. elegans</i> avoids toxin-producing <i>Streptomyces</i> using a seven transmembrane domain chemosensory receptorAlan Tran, Angelina Tang, Colleen T O'Loughlin, et al.
Journal of the National Cancer Institute|April 20, 2001
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancerS M Lippman, J J Lee, D D Karp, et al.
Nature Communications|February 17, 2017
The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategiesZenggang Li, Andrei A Ivanov, Rina Su, et al.
JCI Insight|March 15, 2017
Targeting adhesion signaling in <i>KRAS, LKB1</i> mutant lung adenocarcinomaMelissa Gilbert-Ross, Jessica Konen, Junghui Koo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2020
A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid TumorsTaofeek K Owonikoko, R Donald Harvey, Bradley Carthon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2013
Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studiesDong M Shin, Hongzheng Zhang, Nabil F Saba, et al.
Pageof 97